+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Osteomyelitis Drug"

From
Osteomyelitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Osteomyelitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Osteomyelitis - Pipeline Insight, 2024 - Product Thumbnail Image

Osteomyelitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Osteomyelitis is an infection of the bone and bone marrow caused by bacteria, fungi, or other microorganisms. Infectious Diseases Drugs are used to treat this condition. These drugs are typically antibiotics, antifungals, or antivirals, depending on the type of infection. They are used to reduce inflammation, reduce pain, and prevent further spread of the infection. Commonly prescribed drugs include cephalosporins, fluoroquinolones, and vancomycin. In some cases, surgery may be necessary to remove the infected bone or tissue. The Osteomyelitis Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of pharmaceutical companies that develop and manufacture drugs to treat osteomyelitis. These companies are typically large, multinational corporations that specialize in the research and development of new drugs. Examples of companies in this market include Pfizer, Merck, GlaxoSmithKline, and Sanofi. Show Less Read more